title: GSK fights compensation claims from UK patients who took rosiglitazone.
authors: Clare
authors: C
authors: Dyer
mesh_terms: D035881:Compensation and Redress / Q000331:legislation & jurisprudence*; D004338:Drug Combinations; D004345:Drug Industry / Q000191:economics / Q000331:legislation & jurisprudence*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D008687:Metformin / Q000009:adverse effects; D000077154:Rosiglitazone; D056737:Safety-Based Drug Withdrawals; D013844:Thiazoles / Q000009:adverse effects; D045162:Thiazolidinediones / Q000009:adverse effects*; D006113:United Kingdom
chemical_list: D004338:Drug Combinations; D007004:Hypoglycemic Agents; D013844:Thiazoles; D045162:Thiazolidinediones; C471074:rosiglitazone-metformin combination; D000077154:Rosiglitazone; D008687:Metformin